Search
-
Leading pharmaceutical brands demonstrating leadership
As Covid-19 continues to disrupt traditional care norms, major pharma products have an unprecedented opportunity to define new market dynamics and demonstrate population health leadership.
-
Innovating in challenging times: Research during COVID-19
Doing research during a crisis allows businesses to better predict and prepare for what to do next.
-
Maximizing market foresight in pharma & healthcare
Learn how Dynamic Market Simulation (DMS) can be used to “engineer” your organization’s success, simulating a competitive battle (also known as war gaming) as a proven approach to market foresight.
-
Patient-generated health data
Listen to our on demand webinar to hear Ipsos patient experts share what we have discovered around the perspective of patient influencers.
-
Brand Equity, Behavioral Economics and Surveys
Download this paper to discover how to apply behavioral economics to brand equity and how surveys can be modified to more effectively capture brand equity.
-
Direct-to-Consumer Pharmaceutical Advertising: When to Use Branded Versus Unbranded Campaigns
For many pharmaceutical brands considering DTC, the pursuit of either a branded or unbranded campaign is a critical decision. The best approach can be determined by focusing on several specific factors: the extent to which patients with the disease remain undiagnosed, the amount of fair balance the product requires in a branded ad, and the current market share of the product.